{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:27:43Z","timestamp":1791268063402,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.nmd.2014.04.006","type":"journal-article","created":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T14:02:21Z","timestamp":1398520941000},"page":"583-595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function"],"prefix":"10.1016","volume":"24","author":[{"given":"N.V.","family":"Ermolova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Vetrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.P.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.L.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2014.04.006_b0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/clim.2000.4966","article-title":"Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle","volume":"98","author":"Spencer","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.nmd.2014.04.006_b0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1096\/fj.03-1024com","article-title":"Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis","volume":"18","author":"Grounds","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.nmd.2014.04.006_b0015","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.nmd.2006.06.011","article-title":"Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with etanercept in mdx mice","volume":"16","author":"Hodgetts","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2014.04.006_b0020","first-page":"16","article-title":"Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age","volume":"30","author":"Messina","year":"2011","journal-title":"Acta Myol"},{"key":"10.1016\/j.nmd.2014.04.006_b0025","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1172\/JCI37662","article-title":"Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta","volume":"119","author":"Vetrone","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2014.04.006_b0030","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nm0198-078","article-title":"TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination","volume":"4","author":"Liu","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.nmd.2014.04.006_b0035","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1212\/WNL.45.6_Suppl_6.S44","article-title":"Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors","volume":"45","author":"Selmaj","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2014.04.006_b0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-5728(94)00139-F","article-title":"Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I","volume":"56","author":"Selmaj","year":"1995","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nmd.2014.04.006_b0045","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1084\/jem.172.4.1193","article-title":"An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis","volume":"172","author":"Ruddle","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.nmd.2014.04.006_b0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/WNL.53.3.457","article-title":"TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study.","volume":"53","author":"The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS\/MRI Analysis Group","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2014.04.006_b0055","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/00003246-200107001-00037","article-title":"Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned","volume":"29","author":"Reinhart","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.nmd.2014.04.006_b0060","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0960-8966(00)00160-7","article-title":"Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice","volume":"10","author":"Spencer","year":"2000","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2014.04.006_b0065","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/mus.10431","article-title":"Ventilatory dysfunction in mdx mice: impact of tumor necrosis factor-alpha deletion","volume":"28","author":"Gosselin","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2014.04.006_b0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.nmd.2007.11.002","article-title":"Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment","volume":"18","author":"Radley","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2014.04.006_b0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.nmd.2010.09.013","article-title":"Blockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal mice","volume":"21","author":"Piers","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2014.04.006_b0080","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2990.2007.00798.x","article-title":"Role of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach","volume":"33","author":"Pierno","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.nmd.2014.04.006_b0085","doi-asserted-by":"crossref","first-page":"C1179","DOI":"10.1152\/ajpcell.00062.2005","article-title":"Role of TNF-{alpha} signaling in regeneration of cardiotoxin-injured muscle","volume":"289","author":"Chen","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.nmd.2014.04.006_b0090","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","article-title":"NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia","volume":"289","author":"Guttridge","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.nmd.2014.04.006_b0095","first-page":"871","article-title":"Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha","volume":"12","author":"Li","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.nmd.2014.04.006_b0100","doi-asserted-by":"crossref","first-page":"R1165","DOI":"10.1152\/ajpregu.2000.279.4.R1165","article-title":"NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes","volume":"279","author":"Li","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.nmd.2014.04.006_b0105","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cardfail.2010.03.012","article-title":"Myocardial function with reduced expression of the sodium\u2013calcium exchanger","volume":"16","author":"Jordan","year":"2010","journal-title":"J Card Fail"},{"key":"10.1016\/j.nmd.2014.04.006_b0110","doi-asserted-by":"crossref","first-page":"19371","DOI":"10.1074\/jbc.M802585200","article-title":"Myostatin directly regulates skeletal muscle fibrosis","volume":"283","author":"Li","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2014.04.006_b0115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2014.04.006_b0120","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI8551","article-title":"CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo","volume":"105","author":"Passier","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2014.04.006_b0125","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.CIR.103.5.670","article-title":"Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure","volume":"103","author":"Haq","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.nmd.2014.04.006_b0130","first-page":"1201","article-title":"PTEN\/PI3K pathways are involved in the signal transduction of myocardial remodeling in patients with congestive heart failure","volume":"85","author":"Yang","year":"2005","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.nmd.2014.04.006_b0135","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1074\/jbc.275.12.8271","article-title":"Newton AC: Akt\/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site","volume":"275","author":"Toker","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2014.04.006_b0140","first-page":"61","article-title":"Cloning of the Duchenne\/Becker muscular dystrophy locus","volume":"17","author":"Monaco","year":"1988","journal-title":"Adv Hum Genet"},{"key":"10.1016\/j.nmd.2014.04.006_b0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1083\/jcb.112.1.135","article-title":"Dystrophin\u2013glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma","volume":"112","author":"Ohlendieck","year":"1991","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2014.04.006_b0150","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1083\/jcb.115.6.1685","article-title":"Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice","volume":"115","author":"Ohlendieck","year":"1991","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2014.04.006_b0155","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/hmg\/ddn376","article-title":"Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy","volume":"18","author":"Villalta","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2014.04.006_b0160","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/01.wnl.0000173836.09176.c4","article-title":"Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy","volume":"65","author":"Chen","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2014.04.006_b0165","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2012.10.014","article-title":"Tumor necrosis factor","volume":"328","author":"Chu","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nmd.2014.04.006_b0170","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11906-012-0309-0","article-title":"Mechanisms and consequences of inflammatory signaling in the myocardium","volume":"14","author":"Ahn","year":"2012","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.nmd.2014.04.006_b0175","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.leukres.2005.05.006","article-title":"Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: new insights into the biology of TNF-alpha giving new treatment opportunities \u2013 the role of bupropion","volume":"29","author":"Kast","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.nmd.2014.04.006_b0180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.RES.0000231290.45676.d4","article-title":"Myostatin regulates cardiomyocyte growth through modulation of Akt signaling","volume":"99","author":"Morissette","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.nmd.2014.04.006_b0185","doi-asserted-by":"crossref","first-page":"C1124","DOI":"10.1152\/ajpcell.00043.2009","article-title":"Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt","volume":"297","author":"Morissette","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.nmd.2014.04.006_b0190","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ana.10385","article-title":"Loss of myostatin attenuates severity of muscular dystrophy in mdx mice","volume":"52","author":"Wagner","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2014.04.006_b0195","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1083\/jcb.200108071","article-title":"Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice","volume":"157","author":"Barton","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2014.04.006_b0200","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/hmg\/ddr015","article-title":"Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice","volume":"20","author":"Kim","year":"2011","journal-title":"Hum Mol Genet"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896614001084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896614001084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:02:34Z","timestamp":1760774554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896614001084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0960896614001084"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2014.04.006","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2014.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}